• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ACE2 Elevation in Severe COVID-19.

作者信息

Reindl-Schwaighofer Roman, Hödlmoser Sebastian, Eskandary Farsad, Poglitsch Marko, Bonderman Diana, Strassl Robert, Aberle Judith H, Oberbauer Rainer, Zoufaly Alexander, Hecking Manfred

机构信息

Medical University of Vienna Vienna, Austria.

Attoquant Diagnostics Vienna, Austria and.

出版信息

Am J Respir Crit Care Med. 2021 May 1;203(9):1191-1196. doi: 10.1164/rccm.202101-0142LE.

DOI:10.1164/rccm.202101-0142LE
PMID:33600742
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8314901/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6272/8314901/70ee6b79b831/rccm.202101-0142LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6272/8314901/70ee6b79b831/rccm.202101-0142LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6272/8314901/70ee6b79b831/rccm.202101-0142LEf1.jpg

相似文献

1
ACE2 Elevation in Severe COVID-19.重症新型冠状病毒肺炎中血管紧张素转换酶2的升高
Am J Respir Crit Care Med. 2021 May 1;203(9):1191-1196. doi: 10.1164/rccm.202101-0142LE.
2
Serum ACE as a prognostic biomarker in COVID-19: a case series.血清血管紧张素转换酶作为COVID-19的预后生物标志物：病例系列
APMIS. 2021 Apr;129(4):237-238. doi: 10.1111/apm.13108. Epub 2021 Jan 15.
3
Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19 - implications for post COVID-19 conditions.在 COVID-19 期间外周血单核细胞中 ACE2 表达的减少——对新冠病毒感染后疾病的影响。
BMC Infect Dis. 2024 Jul 3;24(1):663. doi: 10.1186/s12879-024-09321-0.
4
Integrated renin angiotensin system dysregulation and immune profiles predict COVID-19 disease severity in a South African cohort.肾素血管紧张素系统综合失调与免疫特征可预测南非队列中新冠肺炎的疾病严重程度。
Sci Rep. 2025 Apr 14;15(1):12799. doi: 10.1038/s41598-025-96161-w.
5
Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19.在一个大型队列中，可溶性血管紧张素转换酶2（ACE2）的血浆水平与性别、代谢综合征及其生物标志物相关，这表明了COVID-19病情加重的一种可能机制。
Crit Care. 2020 Jul 22;24(1):452. doi: 10.1186/s13054-020-03141-9.
6
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.可溶性血管紧张素转换酶2在新冠病毒病中短暂升高，并与特定的炎症和内皮标志物相关。
J Med Virol. 2021 Oct;93(10):5908-5916. doi: 10.1002/jmv.27144. Epub 2021 Jul 6.
7
Patients with Gaucher disease display systemic elevation of ACE2, which is impacted by therapy status and genotype.戈谢病患者的 ACE2 呈全身性升高，其受治疗状态和基因型的影响。
Mol Genet Metab. 2024 Sep-Oct;143(1-2):108534. doi: 10.1016/j.ymgme.2024.108534. Epub 2024 Jul 9.
8
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.与 COVID-19 相关的危险因素在两个大型心房颤动患者队列中与血管紧张素转换酶 2（ACE2）水平的关系。
Eur Heart J. 2020 Nov 1;41(41):4037-4046. doi: 10.1093/eurheartj/ehaa697.
9
ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases.ACE/ACE2 平衡可能对解释导致严重 COVID-19 病例的某些合并症很重要。
Biosci Rep. 2021 Feb 26;41(2). doi: 10.1042/BSR20202014.
10
Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.COVID-19 患者的肾素-血管紧张素-醛固酮系统肽谱。
Eur J Endocrinol. 2021 Apr;184(4):543-552. doi: 10.1530/EJE-20-1445.

引用本文的文献

1
Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection.血管紧张素转换酶抑制和/或血管紧张素受体阻断调节细胞因子谱并改善实验性 COVID-19 感染的临床结局。
Int J Mol Sci. 2025 Aug 8;26(16):7663. doi: 10.3390/ijms26167663.
2
Targeting carboxypeptidase A/B activity with the phosphinic inhibitor C28 reduces the asthmatic response in a mouse model of house dust mite-induced asthma.使用次膦酸抑制剂C28靶向羧肽酶A/B的活性可减轻屋尘螨诱导的哮喘小鼠模型中的哮喘反应。
Inflamm Res. 2025 May 24;74(1):80. doi: 10.1007/s00011-025-02046-z.
3

本文引用的文献

1
Human recombinant soluble ACE2 in severe COVID-19.严重新型冠状病毒肺炎中的人重组可溶性血管紧张素转换酶2
Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
2
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.
3
Equilibrium Angiotensin Metabolite Profiling in Patients with Acute Respiratory Distress Syndrome Indicates Angiotensin-Converting Enzyme Inhibition.
Angiotensin converting enzyme 2 in patients with sepsis associate with comorbidities but neither with mortality nor with organ failure.
脓毒症患者体内的血管紧张素转换酶2与合并症相关，但与死亡率和器官衰竭均无关。
Sci Rep. 2025 Apr 23;15(1):14198. doi: 10.1038/s41598-025-96640-0.
4
Alterations in the renin-angiotensin system during septic shock.脓毒性休克期间肾素-血管紧张素系统的改变。
Ann Intensive Care. 2025 Mar 24;15(1):40. doi: 10.1186/s13613-025-01463-x.
5
COVID-19 infection and pulmonary sarcoidosis: a systematic review and meta-analysis of morbidity, severity and mortality.新型冠状病毒肺炎感染与肺结节病：发病率、严重程度及死亡率的系统评价与荟萃分析
J Thorac Dis. 2025 Feb 28;17(2):744-752. doi: 10.21037/jtd-24-1620. Epub 2025 Feb 27.
6
The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials.新冠病毒疾病住院患者的循环肾素-血管紧张素系统与死亡率：ACTIV-4宿主组织试验的机制性亚研究
Am J Physiol Lung Cell Mol Physiol. 2025 Mar 1;328(3):L405-L412. doi: 10.1152/ajplung.00372.2024. Epub 2025 Jan 30.
7
Renin-angiotensin-aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study.血浆肾素-血管紧张素-醛固酮系统激活作为COVID-19危重症患者预后的标志物：一项前瞻性探索性研究
Ann Intensive Care. 2025 Jan 16;15(1):10. doi: 10.1186/s13613-025-01433-3.
8
Alterations in the Renin-Angiotensin System in Experimental Septic Shock.实验性脓毒性休克中肾素-血管紧张素系统的改变。
Crit Care Explor. 2024 Oct 11;6(10):e1163. doi: 10.1097/CCE.0000000000001163. eCollection 2024 Oct.
9
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation.通过糖基化调节可溶性血管紧张素转换酶2诱饵受体的药代动力学。
Mol Ther Methods Clin Dev. 2024 Jul 19;32(3):101301. doi: 10.1016/j.omtm.2024.101301. eCollection 2024 Sep 12.
10
Persistent Vascular Complications in Long COVID: The Role of ACE2 Deactivation, Microclots, and Uniform Fibrosis.长新冠中的持续性血管并发症：血管紧张素转换酶2失活、微血栓和均匀纤维化的作用。
Infect Dis Rep. 2024 Jun 27;16(4):561-571. doi: 10.3390/idr16040042.
急性呼吸窘迫综合征患者的平衡血管紧张素代谢物谱显示血管紧张素转换酶受到抑制。
Am J Respir Crit Care Med. 2020 Nov 15;202(10):1468-1471. doi: 10.1164/rccm.201912-2504LE.
4
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
5
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
6
Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction.替代肾素-血管紧张素系统的血管紧张素（Angs）可预测射血分数保留的心力衰竭患者的结局。
Hypertension. 2019 Aug;74(2):285-294. doi: 10.1161/HYPERTENSIONAHA.119.12786. Epub 2019 Jun 24.
7
Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.血管紧张素肽和重组人 ACE2 在心力衰竭中的作用。
J Am Coll Cardiol. 2017 Feb 21;69(7):805-819. doi: 10.1016/j.jacc.2016.11.064.
8
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.血管紧张素转换酶2可预防致死性甲型H5N1禽流感感染。
Nat Commun. 2014 May 6;5:3594. doi: 10.1038/ncomms4594.
9
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.血管紧张素转换酶2（ACE2）在严重急性呼吸综合征冠状病毒诱导的肺损伤中的关键作用。
Nat Med. 2005 Aug;11(8):875-9. doi: 10.1038/nm1267. Epub 2005 Jul 10.